
    
      This is an observational pilot study in patients with definitive relapsing-remitting multiple
      sclerosis to determine whether there is a correlation in serum leptin levels and serum nitric
      oxide levels during a clinically observed increase in disease activity. Each subject will
      followed for 12 months while taking interferon beta-1a subcutaneous injections 3 times a
      week.
    
  